Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Roberts

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Medicine|December 17, 2024
A Pilot Study of PSMA PET/CT and MRI Fusion for Prostate Cancer: Software to Replace PET/MRI HardwareGeorges Mehawed, Matthew J Roberts, Jessica Bugeja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2018
Improved specificity with <sup>68</sup>Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histologyPeter Donato, Matthew J Roberts, Andrew Morton, et al.
Advances in Urology|August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic ReviewStephen McGeorge, Michael Kwok, Andrew Jiang, et al.
BJUI Compass|December 26, 2022
Plain x-ray misses many ureteric calculi: Time to challenge the old dogma?Stephen McGeorge, Brendon Loh, Ryan Shibu, et al.
Familial Cancer|January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
World Journal of Urology|May 6, 2019
Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospitalPeter Donato, Andrew Morton, John Yaxley, et al.
EJNMMI Research|December 20, 2021
Risk of metastatic disease using [<sup>18</sup>F]PSMA-1007 PET/CT for primary prostate cancer stagingVenkata Avinash Chikatamarla, Satomi Okano, Peter Jenvey, et al.
Asian Journal of Urology|February 5, 2024
The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[<sup>18</sup>F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective studyAnthony Franklin, Troy Gianduzzo, Boon Kua, et al.
BJU International|June 20, 2020
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based dataAndrew Morton, Michael Williams, Marlon Perera, et al.
BJU International|September 6, 2019
A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancerMatthew J Roberts, Nathan Papa, Marlon Perera, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Medicine|December 17, 2024
A Pilot Study of PSMA PET/CT and MRI Fusion for Prostate Cancer: Software to Replace PET/MRI HardwareGeorges Mehawed, Matthew J Roberts, Jessica Bugeja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2018
Improved specificity with <sup>68</sup>Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histologyPeter Donato, Matthew J Roberts, Andrew Morton, et al.
Advances in Urology|August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic ReviewStephen McGeorge, Michael Kwok, Andrew Jiang, et al.
BJUI Compass|December 26, 2022
Plain x-ray misses many ureteric calculi: Time to challenge the old dogma?Stephen McGeorge, Brendon Loh, Ryan Shibu, et al.
Familial Cancer|January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
World Journal of Urology|May 6, 2019
Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospitalPeter Donato, Andrew Morton, John Yaxley, et al.
EJNMMI Research|December 20, 2021
Risk of metastatic disease using [<sup>18</sup>F]PSMA-1007 PET/CT for primary prostate cancer stagingVenkata Avinash Chikatamarla, Satomi Okano, Peter Jenvey, et al.
Asian Journal of Urology|February 5, 2024
The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[<sup>18</sup>F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective studyAnthony Franklin, Troy Gianduzzo, Boon Kua, et al.
BJU International|June 20, 2020
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based dataAndrew Morton, Michael Williams, Marlon Perera, et al.
BJU International|September 6, 2019
A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancerMatthew J Roberts, Nathan Papa, Marlon Perera, et al.
Pageof 18